Jim Simons 4 D Molecular Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.03 - $35.87 $1.19 Million - $2.5 Million	69,833 New	69,833 $2.23 Million
Q1 2023 May 12, 2023	SELL	$15.45 - $23.19 $1.77 Million - $2.65 Million	-114,300 Reduced 89.23%	13,800 $237,000
Q4 2022 Feb 13, 2023	BUY	$6.85 - $25.46 $404,150 - $1.5 Million	59,000 Added 85.38%	128,100 $2.85 Million
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.48 $1.33 Million - $2.19 Million	-190,500 Reduced 73.38%	69,100 $556,000
Q2 2022 Aug 12, 2022	BUY	$5.68 - $15.99 $1.08 Million - $3.05 Million	190,500 Added 275.69%	259,600 $1.81 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $22.64 $319,788 - $550,152	24,300 Added 54.24%	69,100 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $876,288 - $1.48 Million	44,800 New	44,800 $983,000

146

57M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $162M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.